Risk of malignancy in histiocytoid Sweet syndrome: A systematic review and reappraisal - 23/07/20
Doi : 10.1016/j.jaad.2020.02.048
Roger Haber, MD a, ⁎ 
, Joelle Feghali, MD b, Maria El Gemayel, MD c
, Joelle Feghali, MD b, Maria El Gemayel, MD c a Department of Dermatology, Saint George Hospital University Medical Center, Beirut, and Faculty of Medicine, University of Balamand, Beirut, Lebanon
b Department of Internal Medicine, Saint George Hospital University Medical Center, Beirut, and Faculty of Medicine, University of Balamand, Beirut, Lebanon
c Department of Internal Medicine, Hotel Dieu de France University Hospital, Beirut, and Faculty of Medicine, Saint Joseph University, Beirut, Lebanon
∗Correspondence to: Roger Haber, MD, Saint George Hospital University Medical Center, Achrafieh, Beirut 166 378 LebanonSaint George Hospital University Medical CenterAchrafieh, Beirut166 378Lebanon
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 2
P. 661-663 - août 2020 Retour au numéro
Article précédent
- Patch testing and contact allergen avoidance in patients with lichen planopilaris and/or frontal fibrosing alopecia: A cohort study
- Sonya Prasad, Dustin H. Marks, Laura J. Burns, Brianna De Souza, Elizabeth A. Flynn, Pamela Scheinman, Dianne Silvestri, JiaDe Yu, Kristen LoSicco, Maryanne M. Senna
- Primary imputation methods impact efficacy results in hidradenitis suppurativa clinical trials
- John W. Frew
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?